Pharmacokinetics of evocalcet in secondary hyperparathyroidism patients receiving hemodialysis: first-in-patient clinical trial in Japan
about
Pharmacokinetics of evocalcet in secondary hyperparathyroidism patients receiving hemodialysis: first-in-patient clinical trial in Japan
description
im Januar 2018 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 11 September 2018
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2018
@uk
name
Pharmacokinetics of evocalcet ...... atient clinical trial in Japan
@en
Pharmacokinetics of evocalcet ...... atient clinical trial in Japan
@nl
type
label
Pharmacokinetics of evocalcet ...... atient clinical trial in Japan
@en
Pharmacokinetics of evocalcet ...... atient clinical trial in Japan
@nl
prefLabel
Pharmacokinetics of evocalcet ...... atient clinical trial in Japan
@en
Pharmacokinetics of evocalcet ...... atient clinical trial in Japan
@nl
P2093
P2860
P356
P1476
Pharmacokinetics of evocalcet ...... atient clinical trial in Japan
@en
P2093
Ryutaro Shimazaki
Tadao Akizawa
Takashi Shigematsu
P2860
P304
P356
10.2147/CPAA.S171044
P407
P577
2018-09-11T00:00:00Z